Microbix Biosystems Inc. (TSX:MBX)

Microbix Biosystems Income Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	18.59	25.39	16.51	19.08	18.59
Revenue Growth (YoY)	-26.81%	53.77%	-13.43%	2.60%	76.66%
Cost of Revenue	8.73	10	9.03	7.95	7.55
Gross Profit	9.85	15.39	7.48	11.12	11.04
Selling, General & Admin	9.1	9.37	8.17	6.72	5.17
Research & Development	2.33	2.13	2.05	1.8	1.03
Operating Expenses	11.43	11.49	10.22	8.51	6.21
Operating Income	-1.58	3.9	-2.74	2.61	4.84
Interest Expense	-0.95	-0.92	-0.84	-0.83	-1.6
Interest & Investment Income	0.35	0.69	0.46	0.08	0
Currency Exchange Gain (Loss)	-0.13	0.01	-	-	-
Other Non Operating Income (Expenses)	-	-0	-	-	-
EBT Excluding Unusual Items	-2.3	3.67	-3.12	1.87	3.23
Asset Writedown	-	-	3.08	-	-
Pretax Income	-2.3	3.67	-0.04	1.87	3.23
Income Tax Expense	-0.06	0.15	-	0.08	-
Net Income	-2.25	3.52	-0.04	1.79	3.23
Net Income to Common	-2.25	3.52	-0.04	1.79	3.23
Net Income Growth	-	-	-	-44.68%	-
Shares Outstanding (Basic)	139	138	138	135	115
Shares Outstanding (Diluted)	139	138	138	142	142
Shares Change (YoY)	0.48%	0.42%	-2.67%	0.00%	35.14%
EPS (Basic)	-0.02	0.03	-0.00	0.01	0.03
EPS (Diluted)	-0.02	0.03	-0.00	0.01	0.03
EPS Growth	-	-	-	-49.98%	-
Free Cash Flow	-0.88	2.71	-2.11	1.44	0.86
Free Cash Flow Per Share	-0.01	0.02	-0.01	0.01	0.01
Gross Margin	53.02%	60.61%	45.30%	58.32%	59.40%
Operating Margin	-8.48%	15.35%	-16.57%	13.68%	26.01%
Profit Margin	-12.08%	13.86%	-0.24%	9.38%	17.39%
Free Cash Flow Margin	-4.72%	10.68%	-12.78%	7.55%	4.65%
EBITDA	-0.14	5.19	-1.9	3.33	5.39
EBITDA Margin	-0.75%	20.46%	-11.48%	17.45%	28.97%
D&A For EBITDA	1.44	1.3	0.84	0.72	0.55
EBIT	-1.58	3.9	-2.74	2.61	4.84
EBIT Margin	-8.48%	15.35%	-16.57%	13.68%	26.01%
Effective Tax Rate	-	4.10%	-	4.14%	-
Revenue as Reported	18.59	25.39	16.51	19.08	18.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.